相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era
Li Tao et al.
BLOOD (2014)
Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data
Antonio Palumbo et al.
LANCET ONCOLOGY (2014)
Racial Disparities in Survival for Patients With Clinically Localized Prostate Cancer Adjusted for Treatment Effects
Mark D. Tyson et al.
MAYO CLINIC PROCEEDINGS (2014)
Second Primary Malignancies after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
Amrita Y. Krishnan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics
Wong-Ho Chow et al.
CANCER (2013)
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
L. E. Roeker et al.
LEUKEMIA (2013)
Patterns of second primary malignancy risk in multiple myeloma patients before and after the introduction of novel therapeutics
P. Razavi et al.
BLOOD CANCER JOURNAL (2013)
Second malignancies after multiple myeloma: from 1960s to 2010s
Anish Thomas et al.
BLOOD (2012)
Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation
Roland Fenk et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups
Sikander Ailawadhi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Continuous Lenalidomide Treatment for Newly Diagnosed Multiple Myeloma
Antonio Palumbo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
Philip L. McCarthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)
Sham Mailankody et al.
BLOOD (2011)
Renal cell cancer among African Americans: an epidemiologic review
Loren Lipworth et al.
BMC CANCER (2011)
Racial disparities in incidence and outcome in multiple myeloma: a population-based study
Adam J. Waxman et al.
BLOOD (2010)
Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group
Kathy S. Albain et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Patterns of monoclonal gammopathy of undetermined significance and multiple myeloma in various ethnic/racial groups: support for genetic factors in pathogenesis
O. Landgren et al.
LEUKEMIA (2009)
Prevalence of monoclonal gammopathy of undetermined significance: Study of 52,802 persons in Nagasaki city, Japan
Masako Iwanaga et al.
MAYO CLINIC PROCEEDINGS (2007)
Myelodysplastic syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma
D. Przepiorka et al.
BONE MARROW TRANSPLANTATION (2007)
Risk patterns of multiple myeloma in Los Angeles County, 1972-1999 (United States)
Mulugeta Gebregziabher et al.
CANCER CAUSES & CONTROL (2006)
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States
O Landgren et al.
BLOOD (2006)
Myeloma and race: A review of the literature
M Benjamin et al.
CANCER AND METASTASIS REVIEWS (2003)
Incidence of hematological malignancies in Martinique, French West Indies, overrepresentation of multiple myeloma and adult T cell leukemia/lymphoma
C Besson et al.
LEUKEMIA (2001)